<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Graft failure is a life-threatening complication after transplantation of hematopoietic stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>We report a cohort of 11 pediatric patients with <z:hpo ids='HP_0001909'>leukemias</z:hpo> (n=8) and severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n=3) who experienced graft rejection after myeloablative transplantation from mismatched related donors (n=6) or after cord blood or matched unrelated donor transplantation (n=5) </plain></SENT>
<SENT sid="2" pm="."><plain>In the latter, the original donor was not available anymore </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were re-transplanted with CD34(+) selected or CD3/CD19 depleted stem cells from a second, haploidentical donor </plain></SENT>
<SENT sid="4" pm="."><plain>Median time span from diagnosis of rejection to second transplant was 9 days </plain></SENT>
<SENT sid="5" pm="."><plain>Reconditioning regimens comprised total lymphoid irradiation, thiotepa, fludarabine, ATG/OKT3 and were well tolerated </plain></SENT>
<SENT sid="6" pm="."><plain>A median number of 23.5x10(6)/kg stem cells with 95,000/kg residual T-cells were infused </plain></SENT>
<SENT sid="7" pm="."><plain>Sustained engraftment of neutrophiles/platelets and complete donor chimerism was achieved in <z:hpo ids='HP_0000001'>all</z:hpo> patients (ANC&gt;500/microl: 9 (11-32) days) </plain></SENT>
<SENT sid="8" pm="."><plain>No GvHD&gt;grade II was observed </plain></SENT>
<SENT sid="9" pm="."><plain>8/11 patients are disease free (median follow up 1.9 years; 1 year-EFS=72%) </plain></SENT>
<SENT sid="10" pm="."><plain>Causes of <z:hpo ids='HP_0011420'>death</z:hpo> were: <z:e sem="disease" ids="C0032285" disease_type="Disease or Syndrome" abbrv="PNEUM">pneumonitis</z:e>, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, relapse </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, haploidentical transplantation represents a realistic option to rescue patients with graft failure within a short time span, for whom a second donation from the original donor is not available </plain></SENT>
<SENT sid="12" pm="."><plain>The use of different donors may contribute to avoid a second rejection </plain></SENT>
</text></document>